Normal glucose tolerant women with low glycemia during the oral glucose tolerance test have a higher risk to deliver a low birth weight infant.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 14 03 2023
accepted: 22 05 2023
medline: 20 6 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: epublish

Résumé

Data are limited on pregnancy outcomes of normal glucose tolerant (NGT) women with a low glycemic value measured during the 75g oral glucose tolerance test (OGTT). Our aim was to evaluate maternal characteristics and pregnancy outcomes of NGT women with low glycemia measured at fasting, 1-hour or 2-hour OGTT. The Belgian Diabetes in Pregnancy-N study was a multicentric prospective cohort study with 1841 pregnant women receiving an OGTT to screen for gestational diabetes (GDM). We compared the characteristics and pregnancy outcomes in NGT women according to different groups [(<3.9mmol/L), (3.9-4.2mmol/L), (4.25-4.4mmol/L) and (>4.4mmol/L)] of lowest glycemia measured during the OGTT. Pregnancy outcomes were adjusted for confounding factors such as body mass index (BMI) and gestational weight gain. Of all NGT women, 10.7% (172) had low glycemia (<3.9 mmol/L) during the OGTT. Women in the lowest glycemic group (<3.9mmol/L) during the OGTT had compared to women in highest glycemic group (>4.4mmol/L, 29.9%, n=482), a better metabolic profile with a lower BMI, less insulin resistance and better beta-cell function. However, women in the lowest glycemic group had more often inadequate gestational weight gain [51.1% (67) vs. 29.5% (123); p<0.001]. Compared to the highest glycemia group, women in the lowest group had more often a birth weight <2.5Kg [adjusted OR 3.41, 95% CI (1.17-9.92); p=0.025]. Women with a glycemic value <3.9 mmol/L during the OGTT have a higher risk for a neonate with birth weight < 2.5Kg, which remained significant after adjustment for BMI and gestational weight gain.

Sections du résumé

Background
Data are limited on pregnancy outcomes of normal glucose tolerant (NGT) women with a low glycemic value measured during the 75g oral glucose tolerance test (OGTT). Our aim was to evaluate maternal characteristics and pregnancy outcomes of NGT women with low glycemia measured at fasting, 1-hour or 2-hour OGTT.
Methods
The Belgian Diabetes in Pregnancy-N study was a multicentric prospective cohort study with 1841 pregnant women receiving an OGTT to screen for gestational diabetes (GDM). We compared the characteristics and pregnancy outcomes in NGT women according to different groups [(<3.9mmol/L), (3.9-4.2mmol/L), (4.25-4.4mmol/L) and (>4.4mmol/L)] of lowest glycemia measured during the OGTT. Pregnancy outcomes were adjusted for confounding factors such as body mass index (BMI) and gestational weight gain.
Results
Of all NGT women, 10.7% (172) had low glycemia (<3.9 mmol/L) during the OGTT. Women in the lowest glycemic group (<3.9mmol/L) during the OGTT had compared to women in highest glycemic group (>4.4mmol/L, 29.9%, n=482), a better metabolic profile with a lower BMI, less insulin resistance and better beta-cell function. However, women in the lowest glycemic group had more often inadequate gestational weight gain [51.1% (67) vs. 29.5% (123); p<0.001]. Compared to the highest glycemia group, women in the lowest group had more often a birth weight <2.5Kg [adjusted OR 3.41, 95% CI (1.17-9.92); p=0.025].
Conclusion
Women with a glycemic value <3.9 mmol/L during the OGTT have a higher risk for a neonate with birth weight < 2.5Kg, which remained significant after adjustment for BMI and gestational weight gain.

Identifiants

pubmed: 37334297
doi: 10.3389/fendo.2023.1186339
pmc: PMC10272607
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1186339

Informations de copyright

Copyright © 2023 Raets, Van Doninck, Van Crombrugge, Moyson, Verhaeghe, Vandeginste, Verlaenen, Vercammen, Maes, Dufraimont, Roggen, De Block, Jacquemyn, Mekahli, De Clippel, Van Den Bruel, Loccufier, Laenen, Devlieger, Mathieu and Benhalima.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

N Engl J Med. 2005 Jun 16;352(24):2477-86
pubmed: 15951574
Acta Diabetol. 2020 Jun;57(6):661-671
pubmed: 31915927
Nat Rev Endocrinol. 2017 Jan;13(1):50-62
pubmed: 27539244
BMC Pregnancy Childbirth. 2014 Jul 11;14:226
pubmed: 25015413
Acta Diabetol. 2022 Mar;59(3):381-394
pubmed: 34725724
Diabetes Care. 2018 Jul;41(7):e111-e112
pubmed: 29748432
Lancet. 1999 May 22;353(9166):1789-92
pubmed: 10348008
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Diabetes Care. 2001 Sep;24(9):1602-7
pubmed: 11522706
Endocrine. 2017 Mar;55(3):799-808
pubmed: 27981520
J Diabetes. 2010 Sep;2(3):203-11
pubmed: 20923485
Am J Epidemiol. 2001 Sep 15;154(6):514-20
pubmed: 11549556
N Engl J Med. 2009 Oct 1;361(14):1339-48
pubmed: 19797280
J Gynecol Obstet Hum Reprod. 2020 Apr;49(4):101703
pubmed: 32018048
Diabetologia. 2021 Apr;64(4):717-726
pubmed: 33569631
Diabetes Care. 2019 Jan;42(Suppl 1):S61-S70
pubmed: 30559232
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
BMJ Open. 2016 Sep 15;6(9):e010984
pubmed: 27633632
Int J Gynaecol Obstet. 2022 Sep;158(3):585-591
pubmed: 34796491
Diabetes Metab Syndr Obes. 2020 Dec 02;13:4717-4726
pubmed: 33293845
Diabetes Res Clin Pract. 2014 Mar;103(3):341-63
pubmed: 24847517
Diabetes Spectr. 2021 May;34(2):119-132
pubmed: 34149252
World J Diabetes. 2019 May 15;10(5):304-310
pubmed: 31139317
J Womens Health (Larchmt). 2018 Jun;27(6):801-807
pubmed: 29323608
Am J Perinatol. 2021 Jul;38(8):841-847
pubmed: 31986539
Am J Obstet Gynecol. 2018 Feb;218(2S):S745-S761
pubmed: 29422210
Diabetes Metab Res Rev. 2002 Mar-Apr;18(2):96-105
pubmed: 11994900
Int J Behav Nutr Phys Act. 2011 Mar 21;8:19
pubmed: 21418609
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e3110-e3124
pubmed: 33693709
Ultrasound Obstet Gynecol. 2017 Jan;49(1):150-154
pubmed: 27800643
Diabet Med. 2009 Dec;26(12):1198-203
pubmed: 20002470
Diabetes Care. 2020 Jan;43(Suppl 1):S183-S192
pubmed: 31862757
Ann Pediatr Endocrinol Metab. 2018 Mar;23(1):4-8
pubmed: 29609443
Obstet Gynecol. 1998 Jul;92(1):8-12
pubmed: 9649083
Diabetes Res Clin Pract. 2019 Jan;147:111-117
pubmed: 30500544
Obstet Gynecol. 2005 Jun;105(6):1424-8
pubmed: 15932839
Diabetologia. 2003 Jan;46(1):3-19
pubmed: 12637977
J Clin Med. 2018 Oct 13;7(10):
pubmed: 30322138
Diabetologia. 2019 Nov;62(11):2118-2128
pubmed: 31338546
Ginekol Pol. 2018;89(1):25-29
pubmed: 29411343
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Am J Obstet Gynecol. 1989 Sep;161(3):646-53
pubmed: 2782347
Front Endocrinol (Lausanne). 2021 Nov 08;12:781384
pubmed: 34858350

Auteurs

Lore Raets (L)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium.

Lore Van Doninck (L)

Medicine, KU Leuven, Leuven, Belgium.

Paul Van Crombrugge (P)

Department of Endocrinology, Onze-Lieve-Vrouwziekenhuis (OLV) Ziekenhuis Aalst-Asse-Ninove, Aalst, Belgium.

Carolien Moyson (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium.

Johan Verhaeghe (J)

Department of Obstetrics & Gynecology, Universitair Ziekenhuis (UZ) Gasthuisberg, KU Leuven, Leuven, Belgium.

Sofie Vandeginste (S)

Department of Obstetrics & Gynecology, Onze-Lieve-Vrouwziekenhuis (OLV) Ziekenhuis Aalst-Asse-Ninove, Aalst, Belgium.

Hilde Verlaenen (H)

Department of Obstetrics & Gynecology, Onze-Lieve-Vrouwziekenhuis (OLV) Ziekenhuis Aalst-Asse-Ninove, Aalst, Belgium.

Chris Vercammen (C)

Department of Endocrinology, Imelda Ziekenhuis, Bonheiden, Belgium.

Toon Maes (T)

Department of Endocrinology, Imelda Ziekenhuis, Bonheiden, Belgium.

Els Dufraimont (E)

Department of Obstetrics & Gynecology, Imelda Ziekenhuis, Bonheiden, Belgium.

Nele Roggen (N)

Department of Obstetrics & Gynecology, Imelda Ziekenhuis, Bonheiden, Belgium.

Christophe De Block (C)

Department of Endocrinology-Diabetology-Metabolism, Antwerp University Hospital, Edegem, Belgium.

Yves Jacquemyn (Y)

Department of Obstetrics & Gynecology, Antwerp University Hospital, Edegem, Belgium.
Antwerp Surgical Training, Anatomy and Research Centre (ASTARC) and Global Health Institute (GHI), Antwerp University University of Antwerp (UA), Antwerp, Belgium.

Farah Mekahli (F)

Department of Endocrinology, Kliniek St-Jan Brussel, Brussel, Belgium.

Katrien De Clippel (K)

Department of Obstetrics & Gynecology, Kliniek St-Jan Brussel, Brussel, Belgium.

Annick Van Den Bruel (A)

Department of Endocrinology, Algemeen Ziekenhuis (AZ) St. Jan Brugge, Brugge, Belgium.

Anne Loccufier (A)

Department of Obstetrics & Gynecology, Algemeen Ziekenhuis (AZ) St. Jan Brugge, Brugge, Belgium.

Annouschka Laenen (A)

Center of Biostatics and Statistical bioinformatics, KU Leuven, Leuven, Belgium.

Roland Devlieger (R)

Department of Obstetrics & Gynecology, Universitair Ziekenhuis (UZ) Gasthuisberg, KU Leuven, Leuven, Belgium.

Chantal Mathieu (C)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium.

Katrien Benhalima (K)

Department of Endocrinology, University Hospital Gasthuisberg, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH